| Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report C Kearon, EA Akl, J Ornelas, A Blaivas, D Jimenez, H Bounameaux, ... Chest 149 (2), 315-352, 2016 | 9367* | 2016 |
| Oral rivaroxaban for symptomatic venous thromboembolism Einstein Investigators New England Journal of Medicine 363 (26), 2499-2510, 2010 | 3865 | 2010 |
| Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer PS Wells, DR Anderson, M Rodger, JS Ginsberg, C Kearon, M Gent, ... Thrombosis and haemostasis 83 (03), 416-420, 2000 | 2350 | 2000 |
| Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis PS Wells, DR Anderson, M Rodger, M Forgie, C Kearon, J Dreyer, ... New England Journal of Medicine 349 (13), 1227-1235, 2003 | 2019 | 2003 |
| Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using … PS Wells, DR Anderson, M Rodger, I Stiell, JF Dreyer, D Barnes, M Forgie, ... Annals of internal medicine 135 (2), 98-107, 2001 | 1806 | 2001 |
| Value of assessment of pretest probability of deep-vein thrombosis in clinical management PS Wells, DR Anderson, J Bormanis, F Guy, M Mitchell, L Gray, ... The Lancet 350 (9094), 1795-1798, 1997 | 1741 | 1997 |
| Systematic overview of warfarin and its drug and food interactions AM Holbrook, JA Pereira, R Labiris, H McDonald, JD Douketis, ... Archives of internal medicine 165 (10), 1095-1106, 2005 | 1531 | 2005 |
| A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism C Kearon, M Gent, J Hirsh, J Weitz, MJ Kovacs, DR Anderson, AG Turpie, ... New England Journal of Medicine 340 (12), 901-907, 1999 | 1492 | 1999 |
| Use of a clinical model for safe management of patients with suspected pulmonary embolism PS Wells, JS Ginsberg, DR Anderson, C Kearon, M Gent, AG Turpie, ... Annals of internal medicine 129 (12), 997-1005, 1998 | 1447 | 1998 |
| Accuracy of clinical assessment of deep-vein thrombosis PS Wells, J Hirsh, DR Anderson, AWA Lensing, G Foster, C Kearon, ... The Lancet 345 (8961), 1326-1330, 1995 | 1098 | 1995 |
| Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism C Kearon, JS Ginsberg, MJ Kovacs, DR Anderson, P Wells, JA Julian, ... New England Journal of Medicine 349 (7), 631-639, 2003 | 1057 | 2003 |
| Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis N Martel, J Lee, PS Wells Blood 106 (8), 2710-2715, 2005 | 989 | 2005 |
| Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines SM Bates, R Jaeschke, SM Stevens, S Goodacre, PS Wells, ... Chest 141 (2), e351S-e418S, 2012 | 938 | 2012 |
| Rivaroxaban or aspirin for extended treatment of venous thromboembolism JI Weitz, AWA Lensing, MH Prins, R Bauersachs, J Beyer-Westendorf, ... New England Journal of Medicine 376 (13), 1211-1222, 2017 | 804 | 2017 |
| Apixaban to prevent venous thromboembolism in patients with cancer M Carrier, K Abou-Nassar, R Mallick, V Tagalakis, S Shivakumar, ... New England Journal of Medicine 380 (8), 711-719, 2019 | 795 | 2019 |
| Low-molecular-weight heparin in the treatment of patients with venous thromboembolism Columbus Investigators New England Journal of Medicine 337 (10), 657-662, 1997 | 767 | 1997 |
| Interactions of warfarin with drugs and food PS Wells, AM Holbrook, NR Crowther, J Hirsh Annals of internal medicine 121 (9), 676-683, 1994 | 727 | 1994 |
| Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial DR Anderson, SR Kahn, MA Rodger, MJ Kovacs, T Morris, A Hirsch, ... Jama 298 (23), 2743-2753, 2007 | 715 | 2007 |
| Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report LK Moores, T Tritschler, S Brosnahan, M Carrier, JF Collen, K Doerschug, ... Chest 158 (3), 1143-1163, 2020 | 693 | 2020 |
| Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies MH Prins, AWA Lensing, R Bauersachs, B Van Bellen, H Bounameaux, ... Thrombosis journal 11 (1), 1-10, 2013 | 663 | 2013 |
